Study of a drug for actinic keratosis on arms or face
Part of Cancer, Skin clinical trials.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old and in good general health.
- You have at least 4 actinic keratosis spots on your arms (within a 5x5 cm area) or at least 6 on your face (within a 5x5 cm area).
- You have veins that work well for repeat blood draws.
- You are willing to avoid sunbathing, tanning beds, and use a consistent skin care routine without major changes.
- You agree to stop using any skin products on the treated areas starting 8 hours before treatment begins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
This study tests a cream called tirbanibulin (Klisyri) for adults with 4 to 12 actinic keratosis (AK) spots on their face. It aims to see how well the treatment works when applied to a larger area of the face in everyday medical practice.
This study compares a cream with fluorouracil alone to a cream with fluorouracil plus calcipotriene for people with several actinic keratoses (a type of rough, precancerous spot caused by sun damage). The goal is to see if the combination works better.
This trial tests a new gel and light treatment for actinic keratosis (rough, sun-damaged spots) on the arm. It aims to see if it can safely remove these spots and prevent new ones.
Hear when a new Actinic Keratosis (AK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.